As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 Announcement
BMC Series Focus Issues
March: Rare diseases
With the 28th of February marking World Rare Diseases day, the BMC Series this month looks at highlighting research on the Rare diseases that together affect around 10% of the population. Read the full collection of articles here.
February: Neglected Tropical Diseases
With the 30th January marking World Neglected Tropical Diseases (NTD) day, the BMC Series this month looks at highlighting research on the NTDs which threaten more than 1.7 billion people living in the poorest and most marginalized communities worldwide.
Announcing the launch of In Review
BMC Immunology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
Featured article: Simulation Modeling for Immunologists
In this article, authors present a freely available software package for the R programming language called Dynamical Systems Approach to Immune Response Modeling (DSAIRM). This is aimed at researchers with little or no coding experience to aid in their understanding of literature involving simulation modeling and to employ in their own research.
Read MoreArticles
-
-
Comprehensive analysis of immunoglobulin and clinical variables identifies functional linkages and diagnostic indicators associated with Behcet’s disease patients receiving immunomodulatory treatment
-
Trastuzumab immunogenicity development in patients’ sera and in laboratory animals
-
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
-
CD100 modulates cytotoxicity of CD8+ T cells in patients with acute myocardial infarction
-
Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis - a prospective, observational study
-
Characterization of murine macrophages from bone marrow, spleen and peritoneum
-
Transcriptional profiling of the LPS induced NF-κB response in macrophages
-
Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays
-
Significantly reduced CCR5-tropic HIV-1 replication in vitro in cells from subjects previously immunized with Vaccinia Virus
Aims and scope
The journal welcomes submissions in these broad areas of research:
Cellular immunology and immune regulation
Clinical immunology: transplants, autoimmunity, immunodeficiency and vaccines
Immunity to infection and tumours
Immunogenetics, immunogenomics and systems immunology
Allergy and hypersensitivity
Innate Immunity and inflammation
Immunometabolism
Editor
- Tim Shipley, BMC London
Manuscript Editor
- Oliver Cocks, BMC London
Assistant Editor
- Amanpreet Athwal, BMC London
Research Data Support
Authors submitting to this journal can opt to use a new service that will make it easier to share research data.
BMC Series Blog
-
-
Preventing and controlling water pipe smoking
26 February 2021
-
Highlights of the BMC Series – January 2021
15 February 2021
Follow
2019 Journal Metrics
-
Citation Impact
2.495 - 2-year Impact Factor
2.598 - 5-year Impact Factor
0.683 - SNIP (Source-Normalized Impact per Paper)
0.971 - SJR (SCImago Journal Rank)Usage
329,380 Downloads
92 Altmetric Mentions